
ENA 2026
1 interview7 min
ENA Molecular Targets and Cancer Therapeutics Symposium
Interviews and expert commentary from ENA 2026 — study authors and key opinion leaders discuss the findings and their clinical implications.
Official website ↗
Faye Johnson MD PhD, 2026 ENA Targets: Antibody-Drug Conjugate MICVO Targets Extracellular Matrix to Treat Metastatic Head & Neck Cancers After Platinum or Immunotherapy
BARCELONA, Spain—Patients with metastatic head and neck cancers that recurred despite platinum based chemotherapy or immunotherapy had significant responses to treatment with the antibody-drug…
20 November 2026
7 min